Why the study?
Does intravenous glucagon improve clinical outcomes in patients with severe heart failure or cardiogenic shock?
Population
50 patients, including 40 with intractable heart failure and/or cardiogenic shock, and 10 with less severe…
Design
Case_series
Follow-up
In-hospital
Authors
Loading...
May aid select refractory HF cases; hypothesis-generating and should not change practice.
Does intravenous glucagon improve clinical outcomes in patients with severe heart failure or cardiogenic shock?
Intravenous glucagon may provide clinical improvement and facilitate hospital discharge in a subset of patients with severe, intractable heart failure or cardiogenic shock when added to conventional therapy.
Lvoff et al. (1972) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: